From Name:
From Email:
To Name:
To Email:

Optional Message:


Personalized medicine 2014: LDT guidance, more PGx drugs, changing business models, lawsuits galore

from Genome Web

Whatever happened in the field of personalized medicine over the last 12 months, the U.S. Food and Drug Administration-issued plan for regulating laboratory developed tests has stolen the spotlight. The FDA's long-stated intent to regulate LDTs has been and continues to be a divisive, hot-button topic. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063